About Cell Genesys
Cell Genesys is focused on the development and commercialization of novel biological therapies for patients with cancer. The Company's lead product platform is GVAX(R) immunotherapy for cancer, which holds the potential to treat multiple types of cancer including prostate cancer, leukemia, pancreatic cancer and lung cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, California, and has manufacturing operations in Hayward, California.
Facts about Cell Genesys
Facts about Cell Genesys
- Focus : Manufacturer
- Industry : Pharma
